This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

South Korea AI law passes parliament, seen taking effect by early 2026

By Choonsik Yoo ( December 26, 2024, 08:37 GMT | Insight) -- South Korea’s parliament overwhelmingly approved the framework act on artificial intelligence today, making the country the first major player after the EU to enact an overarching law as a strategy to address issues related to AI-driven transformation. The country has repeatedly said that its AI strategy is to prioritize innovation and promotion of industries while avoiding restrictive and prescriptive regulation on expected risk factors. The law is now expected to take effect in early 2026, one year after receiving cabinet approval, likely in early January 2025.South Korea’s parliament overwhelmingly approved the framework act on artificial intelligence today, making the country the first major player after the EU to enact an overarching law as a strategy to address issues related to AI-driven transformation....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections